InvestorsHub Logo
Followers 87
Posts 1163
Boards Moderated 0
Alias Born 09/10/2017

Re: robertmaxwell post# 11192

Monday, 04/16/2018 2:19:55 PM

Monday, April 16, 2018 2:19:55 PM

Post# of 12137
I’m not surprised that you fundamentally disagree rob. To date, DC based vaccines have had limited success (Provenge) and have had numerous trial failures (Immunocellular, Celdex, Argos, etc.), so that statement I made goes against the “conventional wisdom” to which you subscribe. I’ll try to keep this short for you.

I said dendritic cells will be the next big thing because one of Cryoport’s customers presented clinical trial data evaluating autologous dendritic cells at last years ASCO that shows patients are living longer than expected and the trial appears to have a long, fat tail. They are likely to be presenting updated data shortly that may change the “conventional wisdom.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News